Search

everythinglearnresearchcommunity

for

Search:↓

Pregnant women with Systemic Lupus Erythematosus have a higher risk of blood clotting problems.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

New insights in skin conditions show a complex link between certain moles and melanoma, improved hair loss treatments, and the need to identify different types of lupus.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Panniculitis in dermatomyositis is rare, more common in women, and may persist despite treatment.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Type I interferons play a key role in the development of various skin diseases.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Psychotropic medications can cause skin problems but also treat some skin conditions.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

A fungus ball in the lung can cause coughing up blood in SLE patients.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Middle-aged women with dilated cardiomyopathy should be screened for antiphospholipid syndrome.